CS logo
small CS logo
Rocky Mountain Cancer Centers-Sky Ridge

Lone Tree, Colorado, United States
Cancer treatment center in Lone Tree, Colorado
10107 Ridgegate Pkwy Suite 200, Lone Tree, CO 80124

About Rocky Mountain Cancer Centers-Sky Ridge


"Rocky Mountain Cancer Centers (RMCC) is Colorado's largest and most comprehensive provider of cancer care with over 50 physicians, in nearly 20 community-based locations across the state. Our history is rich in forward thinking and best practice development. We were formed in 1992 when a group of independent medical oncology practices joined together to become a network of community-based clinic sites. This practice model has stood the test of time and continues to have proven clinical and economic benefit for patients, employers and payers today."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
73
SWOG Cancer Research Network
32
Alliance for Clinical Trials in Oncology
24
ECOG-ACRIN Cancer Research Group
14
Pfizer
8
NRG Oncology
6
Eli Lilly and Company
5
GOG Foundation
3
Eastern Cooperative Oncology Group
2
Gynecologic Oncology Group
2
BeiGene
1
Total Rows: 29

Clinical Trials at Rocky Mountain Cancer Centers-Sky Ridge


During the past decade, Rocky Mountain Cancer Centers-Sky Ridge conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 70 clinical trials were completed, i.e. on average, 63.1% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 46 clinical trials were completed. i.e. 148.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years8812122121202019191818111122005533661010121217171313Started TrialsCompleted Trails201520162017201820192020202120220102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
2004-09-01
2009-10-01
Completed
1,783
Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
2006-04-01
2009-01-01
Completed
76
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
2006-09-01
2014-06-01
Completed
1,252
Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
2006-11-01
2009-03-01
Completed
75
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
2008-09-03
2016-02-25
Completed
723

Rows per page:

1–100 of 188

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Sky Ridge" #1 sponsor was "National Cancer Institute (NCI)" with 73 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored and "Pfizer" with 14 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 29 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Sky Ridge" #1 collaborator was "National Cancer Institute (NCI)" with 84 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "ARMO BioSciences" with 2 trials as a collaborator and "Astellas Pharma Inc" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 24 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Rocky Mountain Cancer Centers-Sky Ridge


According to Clinical.Site data, the most researched conditions in "Rocky Mountain Cancer Centers-Sky Ridge" are "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Breast Cancer" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Rocky Mountain Cancer Centers-Sky Ridge" in a lesser frequency.

Clinical Trials Intervention Types at Rocky Mountain Cancer Centers-Sky Ridge


Most popular intervention types in "Rocky Mountain Cancer Centers-Sky Ridge" are "Drug" (146 trials), "Other" (110 trials), "Biological" (80 trials), "Procedure" (44 trials) and "Radiation" (14 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Quality-of-Life Assessment" (45 trials), "Questionnaire Administration" (25 trials), "Biospecimen Collection" (24 trials) and "Computed Tomography" (24 trials). Other intervention names were less common.

Clinical Trials Genders at Rocky Mountain Cancer Centers-Sky Ridge


The vast majority of trials in "Rocky Mountain Cancer Centers-Sky Ridge" are 149 trials for "All" genders, 35 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at Rocky Mountain Cancer Centers-Sky Ridge


Currently, there are NaN active trials in "Rocky Mountain Cancer Centers-Sky Ridge". undefined are not yet recruiting, 46 are recruiting, 86 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Rocky Mountain Cancer Centers-Sky Ridge, 5 suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Rocky Mountain Cancer Centers-Sky Ridge, 5 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status